NEC Europe Appoints Hironobu Kurosaki as President and CEO
NEC Europe Ltd. today announced the appointment of Hironobu Kurosaki as President and CEO. In this role, Mr. Kurosaki will lead the growth of NEC Europe’s business for a broad range of customers spanning across its key business segments of Public Safety, Public IT services and Telecom Carrier Solutions in the EMEA region (Europe, the Middle East and Africa).
Since joining NEC in 1983, Mr. Kurosaki has gained extensive international experience in the development of sales, marketing and strategy throughout the Americas and EMEA.
In recent years, he has played a leading role in the development of NEC’s global business, where his experience as President of NEC Telecommunication and Information Technology Ltd. (Turkey), and contributions as General Manager of NEC’s Americas and EMEA Division have helped to deliver high-powered solutions and drive new growth in strategic markets.
“In the face of terrorism and other public threats, it is becoming a top priority throughout EMEA to strengthen the security and surveillance of borders, public spaces and major infrastructure, such as airports,” said Mr. Kurosaki. “There are now a wide range of initiatives being started in order to ensure the safety, security and efficiency of our cities. NEC’s Information and Communication Technologies (ICT) and solutions make valuable contributions to these initiatives and help ensure that cities throughout EMEA are safer and smarter.”
“I look forward to further addressing these important needs and creating new social value by capitalizing on NEC's ICT, including some of the world’s leading Artificial Intelligence (AI) and Internet of Things (IoT) advancements, while building on the relationships of trust we hold with our customers and partners.”
About NEC Europe Ltd.
NEC Europe is a wholly owned subsidiary of NEC Corporation, a leader in the integration of IT network technologies that benefit businesses and people around the world. As one of NEC Corporation’s regional headquarters, NEC Europe promotes innovation throughout Europe, the Middle East and Africa (EMEA) by providing its expertise, solutions and services to a broad range of customers, from telecom operators to enterprises and public sector organizations. For additional information, please visit the NEC Europe home page at: http://uk.nec.com/
NEC is a registered trademark of NEC Corporation. All Rights Reserved. Other product or service marks mentioned herein are the trademarks of their respective owners. ©2017 NEC Corporation.
Joseph Jasper, +81-3-3798-6511
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
New Guidance From ADA and EASD Recommends Use of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors and Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Patients with Type 2 Diabetes16.10.2018 16:15 | Tiedote
As the European distributor of INVOKANA ® (canagliflozin) and VOKANAMET ® (canagliflozin and metformin) Mundipharma welcomes the news that SGLT2i’s, including canagliflozin, have now been included as an important treatment option in the newly published 2018 ADA/EASD Consensus Report in the early management of T2DM patients with established ASCVD, HF, CKD and also in patients without cardiovascular disease (CVD) especially where there is a compelling need to minimize weight gain or promote weight loss or a need to minimize the risk of hypoglycaemia. The new guidance was co-published in Diabetologia, the journal of EASD, and Diabetes Care, the journal of the ADA, during the annual meeting of EASD in Berlin, Germany on October 5.1 Updates to the guidance took into consideration recent evidence from large CV outcome trials (CVOTs), which included the CANVAS programme, the largest completed and published CV outcomes trial to date for an SGLT2i, which has shown that canagliflozin reduces the
Brightree Launches First Patient App for HME16.10.2018 16:05 | Tiedote
Brightree®, the leading provider of cloud-based software to help post-acute care companies improve business performance and patient outcomes, announced today from Medtrade the release of its new Patient Hub to personalize the patient experience and increase revenue for home medical equipment (HME) providers. Patient Hub is a patient engagement app that automates and simplifies how HME providers connect with their patients. It eliminates the need for multiple web portals and consolidates all patient interactions into one secure platform. By improving ease of engagement and automation, Patient Hub empowers care, frees up resources and creates opportunities to accelerate cash flow. The Patient Hub app allows providers to automate simple, repetitive processes such as sending out appointment reminders and requests for insurance updates, or delivering order status and tracking updates. Patients can initiate and complete tasks as well, including updating account information, reordering suppli
KYMCO Announces Entry Into India With Ionex16.10.2018 15:40 | Tiedote
KYMCO announces its official entry into India with its game-changing Ionex electric scooter total solution. In partnership with Twenty Two Motors, an Indian company that focuses on developing advanced connected electric vehicles, KYMCO is set to revolutionize the two-wheeler sector in India by bringing the new era of electric scooters and building the open energy platforms long awaited by Indian customers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181016005636/en/ Allen Ko, Chairman, KYMCO (Photo: Business Wire) India is the largest two-wheeler market in the world. The Indian government is actively promoting green movement through policies that encourage the use of electric vehicles as well as the establishment of EV infrastructure. The latest ‘National E-Mobility Programme’ aims to shift one third of petrol and diesel vehicles to electric by 2030. The government has a strong motivation for “go electric, go green” revol
Fujitsu to Demonstrate New “Super-Slim” Washable RFID Linen Tags at the EXPOdetergo 18th International Exhibition in Milan, Italy16.10.2018 15:00 | Tiedote
Fujitsu Frontech North America Inc., a leader in innovative technology and front-end solutions, has announced today that Fujitsu has developed a new line of washable UHF RFID tags only 7 millimeters wide, 30% smaller than current tags, allowing them to be more easily inserted into the seams of washable items. Fujitsu will debut the new “super-slim” tags, as well as their WT-A533 Linen tags and WT-A533L Fashion tags, at the EXPOdetergo 18th International Exhibition, Hall 1 booth # V10, on October 19-22, 2018, at the Fiera Milano Convention Center, Milan, Italy. The Fujitsu “super-slim” washable RFID Linen tags are targeted for availability in the first quarter of 2019. “Fujitsu has been creating RFID solutions for over 20 years. Our engineering and design teams possess sophisticated engineering, design and antenna optimization intellectual property,” says Michi Sugawara, President and CEO of Fujitsu Frontech North America Inc. “By combining this know-how plus our skills in high-volume,
Quotient Sciences Constructs State-of-the-Art Early-Phase Formulation and Manufacturing Facility in U.S.16.10.2018 15:00 | Tiedote
Quotient Sciences, a leading drug development services organization, announces a significant expansion to its operations in the U.S. with the opening of a state-of-the-art, 45,000-square-foot facility located near Philadelphia, in Garnet Valley, Pa. The $15 million investment will create a center of excellence for early-phase formulation development and clinical trial manufacturing. The Garnet Valley site will focus on developing small molecule oral drug products, supporting development programs from the preclinical stage through to clinical proof-of-concept. Seamless scale-up to late-phase manufacturing and commercial product supply will continue at Quotient’s nearby Chelsea Parkway facility. “Our new facility was built in response to increasing customer demand for our early-phase formulation development and clinical trial manufacturing services,” said Mark Egerton, Ph.D., CEO of Quotient Sciences. “The site was specifically designed to optimize our ability to work with highly potent
PotNetwork Holdings, Inc. Releases PCAOB Fully Audited and Reviewed Financial Statements under Its Registration as an SEC Reporting Company16.10.2018 15:00 | Tiedote
PotNetwork Holdings, Inc. (OTC Pink:POTN) has successfully filed its Form 10 registration statement with the U.S. Securities and Exchange Commission (“SEC”), which included independent third party PCAOB (“Public Company Accounting Oversight Board”) auditor certification of its financial performance for all of 2017 and verification of its financial results through the first 6 months of 2018. Going forward, all such financial information will be PCAOB auditor verified. Through submission of the filing, the Company has voluntarily become subject to the full disclosure requirements of the SEC for reporting companies, and the Company must have each quarter’s fiscal performance PCAOB auditor reviewed and its year-end statements fully audited by a PCAOB member firm. Now as a reporting company, PotNetwork Holdings, Inc. qualifies for uplisting to the OTCQB market tier. The PCAOB sets the auditing standards for its member firms, and performs inspections of member firm audits of public companies
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme